Evidence map›Paper›PMID 28489415›Full record

ArticleAmerican journal of respiratory cell and molecular biology2017

Hepatic Steatosis Accompanies Pulmonary Alveolar Proteinosis.

Alan N Hunt, Anagha Malur, Tual Monfort, Pavlos Lagoudakis, Sumeet Mahajan, Anthony D Postle, Mary Jane Thomassen

Open access · greenAbstract read
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. The dark side of pulmonary alveolar proteinosis.Multidisciplinary respiratory medicine · 2025
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Lipid phenotyping of lung epithelial lining fluid in healthy human volunteers.Metabolomics : Official journal of the Metabolomic Society · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 4 countries.

Alan N Hunt1 Clinical and Experimental Sciences, Faculty of Medicine.ORCID 0000-0001-5938-2152
Anagha Malur2 Division of Pulmonary, Critical Care and Sleep Medicine, Brody School of Medicine, East Carolina University, Greenville, North Carolina.
Tual Monfort3 Institute for Life Sciences, and.
Pavlos Lagoudakis4 School of Physics and Astronomy, University of Southampton, Southampton, United Kingdom; and.ORCID 0000-0002-3557-5299
Sumeet Mahajan3 Institute for Life Sciences, and.ORCID 0000-0001-8923-6666
Anthony D Postle1 Clinical and Experimental Sciences, Faculty of Medicine.ORCID 0000-0001-7361-0756
Mary Jane Thomassen2 Division of Pulmonary, Critical Care and Sleep Medicine, Brody School of Medicine, East Carolina University, Greenville, North Carolina.ORCID 0000-0003-1229-7668
Center for Life Sciences · CNEast Carolina University · USInstitute of Clinical and Experimental Medicine · CZUniversity of Southampton · GB

Funding

Wellcome TrustWellcome Trust 057405
6 · The paper itself

Abstract

Maintenance of tissue-specific organ lipid compositions characterizes mammalian lipid homeostasis. The lungs and liver synthesize mixed phosphatidylcholine (PC) molecular species that are subsequently tailored for function. The lungs progressively enrich disaturated PC directed to lamellar body surfactant stores before secretion. The liver accumulates polyunsaturated PC directed to very-low-density lipoprotein assembly and secretion, or to triglyceride stores. In each tissue, selective PC species enrichment mechanisms lie at the heart of effective homeostasis. We tested for potential coordination between these spatially separated but possibly complementary phenomena under a major derangement of lung PC metabolism, pulmonary alveolar proteinosis (PAP), which overwhelms homeostasis and leads to excessive surfactant accumulation. Using static and dynamic lipidomics techniques, we compared (1) tissue PC compositions and contents, and (2) in lungs, the absolute rates of synthesis in both control mice and the granulocyte-macrophage colony-stimulating factor knockout model of PAP. Significant disaturated PC accumulation in bronchoalveolar lavage fluid, alveolar macrophage, and lavaged lung tissue occurred alongside increased PC synthesis, consistent with reported defects in alveolar macrophage surfactant turnover. However, microscopy using oil red O staining, coherent anti-Stokes Raman scattering, second harmonic generation, and transmission electron microscopy also revealed neutral-lipid droplet accumulations in alveolar lipofibroblasts of granular macrophage colony-stimulating factor knockout animals, suggesting that lipid homeostasis deficits extend beyond alveolar macrophages. PAP plasma PC composition was significantly polyunsaturated fatty acid enriched, but the content was unchanged and hepatic polyunsaturated fatty acid-enriched PC content increased by 50% with an accompanying micro/macrovesicular steatosis and a fibrotic damage pattern consistent with nonalcoholic fatty liver disease. These data suggest a hepatopulmonary axis of PC metabolism coordination, with wider implications for understanding and managing lipid pathologies in which compromise of one organ has unexpected consequences for another.

Indexed as

AnimalsFatty LiverFemaleLiverMacrophages, AlveolarMaleMiceMice, KnockoutOrgan SpecificityPhosphatidylcholinesPulmonary Alveolar ProteinosisPulmonary AlveoliPhosphatidylcholinesfibrotic damagehepatic steatosislipidomicslipotoxicitypulmonary alveolar proteinosis

Identifiers

PMID28489415
PMCPMC5650083
OpenAlexW2613493641

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.